Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$29,732,770
+$737,174 QoQ
Shares Held
251,525
+9.1% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Northwest & Ethical Investments L.P. holds $35,891,165 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (82.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
251,525 | $29,732,770 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
5,650 | $3,350,337 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,470 | $977,996 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
61,692 | $854,434 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
31,019 | $742,284 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
43,212 | $233,344 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,732,770 | 251,525 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $28,995,596 | 230,453 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $36,964,967 | 252,631 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,550,495 | 86,890 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,908,626 | 23,739 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,886,270 | 29,990 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,471,331 | 38,240 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,968,031 | 40,194 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,591,744 | 38,956 | Shares | Sole | 2025-07-09 | |
| 2023-12-31 | $6,564,328 | 33,259 | Shares | Sole | 2025-07-09 | |
| 2023-09-30 | $5,786,400 | 33,259 | Shares | Sole | 2025-07-09 | |
| 2023-06-30 | $5,727,532 | 33,259 | Shares | Sole | 2025-07-09 | |
| 2023-03-31 | $5,535,627 | 33,259 | Shares | Sole | 2025-07-09 | |
| 2022-12-31 | $4,705,573 | 32,109 | Shares | Sole | 2025-07-09 | |
| 2022-09-30 | $4,198,979 | 28,316 | Shares | Sole | 2025-07-09 | |
| 2022-06-30 | $4,413,275 | 25,675 | Shares | Sole | 2025-07-09 | |
| 2022-03-31 | $4,483,727 | 23,775 | Shares | Sole | 2025-07-09 | |
| 2021-12-31 | $7,858,986 | 32,205 | Shares | Sole | 2025-07-09 | |
| 2021-09-30 | $5,635,690 | 29,029 | Shares | Sole | 2025-07-09 | |
| 2021-06-30 | $5,409,844 | 29,029 | Shares | Sole | 2025-07-09 | |
| 2021-03-31 | $5,593,689 | 35,520 | Shares | Sole | 2025-07-09 | |
| 2020-12-31 | $6,576,804 | 39,739 | Shares | Sole | 2025-07-08 | |
| 2020-09-30 | $7,567,827 | 45,763 | Shares | Sole | 2025-07-08 | |
| 2020-06-30 | $5,923,828 | 43,227 | Shares | Sole | 2025-07-08 | |
| 2020-03-31 | $4,946,157 | 42,027 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||